Question · asked by 1 review

Oral cyclobenzaprine (muscle relaxant) vs placebo: Jaw pain (VAS)

Population
Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of minimum 3 months' duration
Intervention
Oral cyclobenzaprine (muscle relaxant)
Comparison
placebo
Outcome
Jaw pain (VAS)

Oral cyclobenzaprine (muscle relaxant) showed no clear difference in jaw pain (VAS) compared with placebo; GRADE not reported.

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Oral cyclobenzaprine (muscle relaxant) vs Placebo
Jaw pain (VAS) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to… · 3 weeks
Oral cyclobenzaprine (muscle relaxant) showed no clear difference in jaw pain (VAS) compared with placebo; GRADE not reported.
Pharmacological interventions for pain in patients with temporomandibular disorders (2010) · Cochrane All outcomes
MD -1.30 [-2.67, 0.07]1 study · 41 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Pharmacological interventions for pain in patients with temporomandibular disorders
2010 · Cochrane All outcomes
2010-08Not listedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.